U.S. Medical Equipment Stock News

Whirlpool stock ripped higher, jumping 13.8% to US$44.62, as investors grabbed for a quick rebound story in a company that has spent the last year grinding through profit pressure and balance sheet fixes. The headline this quarter is margin, not sales. Management delivered a slim 1.8% ongoing operating margin on about US$3.5b of Q2 revenue and still expects only about 4% for the full year. For a global appliance manufacturer with heavy debt and rising interest costs, that kind of margin...

Bank OZK (OZK) has drawn fresh attention after its recent share price moved around current valuations, with the stock closing at $52.24. Investors are examining how this development relates to the bank’s broader fundamentals. See our latest analysis for Bank OZK. Over the past year, Bank OZK has combined a 11.05% year to date share price return with a 11.45% 1 year total shareholder return, while its 3 year and 5 year total shareholder returns of 35.41% and 45.80% hint at gradually building...

Why Alignment Healthcare’s latest earnings matter for investors Alignment Healthcare (ALHC) has drawn fresh attention after reporting second quarter 2026 results and updating its revenue outlook, putting recent stock volatility and ongoing legal investigations into sharper focus for investors. See our latest analysis for Alignment Healthcare. Despite stronger recent earnings and higher guidance, Alignment Healthcare’s share price has come under heavy pressure, with a 30 day share price return...

DuPont de Nemours stock edged up about 1% in regular trading after its latest earnings, a muted move for a company that just lifted guidance and put fresh cash flow on the table. Short term traders are reacting to a neat quarter built on 4% organic sales growth and adjusted earnings per share of US$1.88. Long term investors will likely care more about what sits behind that print. The core industrial and healthcare franchises are now generating higher operating margins and strong free cash...

Everest Group stock barely flinched after earnings, slipping about 0.8% to roughly US$369 and leaving the 7 day move only modestly in the red. That calm surface hides a stronger story. The insurer just posted quarterly basic earnings per share of US$14.23 on US$4.0b in revenue with a combined ratio of 92%. For a property and casualty player, that underwriting result is the headline. The market looks more hesitant than impressed, which raises a clear question for investors about whether short...

Why Principal Financial Group Stock Is Back on Investor Radars Principal Financial Group (PFG) has drawn fresh attention after reporting second quarter 2026 results that showed higher revenue, broadly steady net income, and slightly higher earnings per share compared with a year earlier. See our latest analysis for Principal Financial Group. Principal Financial Group’s share price has gained 3.9% over the past month and 28.9% year to date, while the 1 year total shareholder return of 56.9%...

Record highs for the S&P 500 and Dow, softer Treasury yields and sharp moves in oil and tech are reshaping where dividend growth stocks may fit in a portfolio. With corporate earnings surprising to the upside and AI linked tech stocks back in focus, investors looking for growing income streams now have a fresh backdrop to consider. This article walks through 3 dividend growth stocks from our screener that appear closely tied to these market drivers. The goal is to help you decide whether...

Zimmer Biomet’s recently reported second-quarter results highlighted ongoing strength in its hip triple-play and knee portfolios, even as analysts reassessed the company’s muted revenue growth and modest 4.2% return on capital in light of its long operating history and global scale. The key tension now is between solid procedural demand in core orthopedics and growing concern that management has limited avenues for highly profitable expansion. Next, we’ll explore how this mix of resilient...

The market wasted no time rewarding AMETEK. The stock jumped 4.2% to US$254.05 in the first session after results, extending a strong run into the print. That kind of move typically occurs when the earnings story aligns with expectations. For AMETEK, the headline is clear. Q2 revenue reached about US$2.0b and net income came in above US$400m, both supported by high margins and strong free cash flow conversion. Traders are reacting to a report that shows demand and profitability in its...

Reservoir Media entered this report with a relatively high P/E and a stock that had drifted slightly over the past month. The first look at Q1 numbers did not spark a rally. Shares slipped about 1% to US$10.06 after the release, even though revenue reached about US$41.5 million and adjusted earnings before interest, tax, depreciation and amortization (EBITDA) was US$15.7 million. The headline is simple: the music catalog story is still growing at the top line, but higher interest costs and a...

Energizer Holdings stock ticked up 2.2% to US$21.58 after earnings, a modest move for a quarter that sharply reset the profit story. The headline is margin repair. Quarterly basic earnings per share came in at about US$0.58 on revenue of US$734.1m, a much healthier profit print than earlier in the fiscal year. For a company often viewed as a steady battery cash machine with a stretched balance sheet, this report focuses on whether improving profitability can keep powering the equity case. The...

Sunoco stock closed at US$74.33, down about 4% on the day, even as the company posted one of its cleanest profit beats in recent quarters. The core story is not the single quarter earnings per share print. The headline is the upgraded full year adjusted earnings before interest, tax, depreciation and amortization guidance to US$3.5b to US$3.7b, backed by almost US$1b of adjusted EBITDA in the quarter. Short term traders focused on the price drop. Long term holders are looking at that higher...

Bancorp (TBBK) has drawn fresh attention after reporting second quarter 2026 results, updating earnings guidance for 2026 and 2027, detailing lower net charge offs, completing a share repurchase, and receiving affirmed credit ratings. See our latest analysis for Bancorp. The latest earnings update, lower net charge offs, completed buyback and affirmed credit ratings appear to have supported renewed interest in Bancorp, with a 19.16% 90 day share price return and a 5 year total shareholder...

Shoals Technologies Group stock slipped 1.6% to US$9.22 the day after earnings, which is a muted reaction for a company often treated as a high growth solar hardware story. The headline is simple: Shoals reported solid Q2 execution with about US$163.4m in revenue and adjusted earnings before interest, tax, depreciation and amortization of US$31.6m, both in line with what management had guided. For investors who came in on the back of that premium P/E and big expectations around utility scale...

Kimberly-Clark stock shook off a softer recent stretch and jumped 3.7% to US$111.57 in the first full session after Q2 results. That move came after a week and month where the shares had drifted lower, so the market clearly liked something in this report. The headline is profit resilience in a choppy quarter. Q2 basic earnings per share landed at US$1.22 on revenue of US$4.19b, with net income from ongoing operations at US$405m despite issues like China diaper disruption and North America...

Viemed Healthcare stock just took a heavy hit, dropping almost 16% to about US$9.84, even though the latest quarter showed revenue of US$78.1m and basic earnings per share of roughly US$0.07. The market is clearly trading the headline move rather than the longer story. Step back from today’s red screen and a different picture starts to form. On a trailing basis Viemed Healthcare is earning about US$0.38 per share, carries a P/E of 25.8x, and is trading well below one discounted cash flow...

The market cheered Arvinas with an 11.7% jump to about $9, yet the real headline sits in the income statement. A biotech that many investors still file mentally under early stage clinical story just printed Q2 basic earnings per share of $2.61 on revenue of $249.7m, driven by licensing and collaboration flows. Coming into the release, the stock had drifted over the past three months, with a weaker 90 day return despite modest gains in the last week and month. Today's move is the market trying...

The market is giving DigitalOcean Holdings a cautious nod rather than a standing ovation. The stock is up about 1.4% today after a choppy few months, which is a mild reaction to a quarter that put hard numbers behind the AI cloud story. Revenue reached US$281.2m with roughly 29% year over year growth, while adjusted EBITDA margin held at a hefty 40%. For investors, the sentiment gap is clear. The price is already rich on a P/E of 64.1x, yet this print shows a business generating cash and...

Crinetics Pharmaceuticals stock barely budged today, up just 0.1%, which suggests sentiment has not caught up with what the income statement is showing. The headline is simple: this is a high growth biotech story where revenue is now material, yet the losses remain heavy. Quarterly revenue reached US$25.1 million, a sharp step up for a company that only recently started booking meaningful product sales. At the same time, Crinetics Pharmaceuticals reported a quarterly net loss of US$120.9...

ZTO Express (Cayman) stock has returned 25.4% over the past year, yet valuation checks and the intrinsic value estimate both still point to the shares trading below what the cash flows suggest they may be worth. With the current price at US$23.98 and both the Discounted Cash Flow (DCF) model and market multiples signaling undervaluation, investors are weighing how much of that gap can reasonably close. The 25.4% one year return indicates that sentiment toward ZTO Express (Cayman) has been...

Ciena (CIEN) is in focus after Quantum Corridor and Toshiba completed a live network trial using Ciena’s WaveLogic 6 Extreme 1.6 Tb/s quantum safe encryption, combining post quantum cryptography with quantum key distribution. See our latest analysis for Ciena. Against this quantum networking backdrop, Ciena’s 1-day share price return of 5.21% and 7-day share price return of 17.29% sit alongside a share price that is down 28.72% over 90 days, but paired with a 1-year total shareholder return...

AdaptHealth stock just absorbed a brutal judgment from the market, plunging 38% to US$6.71 after its Q2 release. Investors focused on a sharp reset to full year adjusted EBITDA guidance and a fresh loss from continuing operations, rather than the solid top line of US$740.3 million and double digit growth in core Sleep and Respiratory. The short term readout is simple: profitability pressure is front and center. The bigger story now runs through the next few years. AdaptHealth is leaning hard...

In early August 2026, News Corporation was reported to have delivered a resilient fourth-quarter performance, with digital-first businesses and the Dow Jones segment helping offset macroeconomic headwinds, while the U.S. housing market eased into its typical summer slowdown with moderating listing prices but steady buyer interest. A key insight is that Dow Jones’s business-critical digital offerings and News Corp’s operational discipline, including its accelerated share repurchase program,...

ON Semiconductor stock inched up less than 1% to about US$80.78, even after a quarter that sharply swung earnings back into the black. The market reaction looks muted compared with the headline shift from a loss in Q1 to Q2 basic earnings per share of about US$0.58 on revenue of US$1.60b. The near term story is the earnings recovery. The longer term question is whether that rebound, together with a trailing P/E near 50x and stronger profitability, is enough to reset how investors value ON...